Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells
about
Gelatinase B/MMP-9 in Tumour Pathogenesis and ProgressionLate SV40 factor (LSF) enhances angiogenesis by transcriptionally up-regulating matrix metalloproteinase-9 (MMP-9)Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic nicheTIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in miceInfluence of Immune Myeloid Cells on the Extracellular Matrix During Cancer MetastasisThe tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?Tumor endothelial cellsVasculogenesis: a crucial player in the resistance of solid tumours to radiotherapyMyeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implicationsRadiotherapy and the tumor stroma: the importance of dose and fractionationSelective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal CancerEffects of high-dose microbeam irradiation on tumor microvascular function and angiogenesis.MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study.Radiation-induced immune responses: mechanisms and therapeutic perspectivesSignal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapyInhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decadeReplication Study: The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumorsCross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in vivoStromal cell-derived factor-1/CXCL12 contributes to MMTV-Wnt1 tumor growth involving Gr1+CD11b+ cellsMatrix metalloproteinases: regulators of the tumor microenvironmentEnhanced cancer radiotherapy through immunosuppressive stromal cell destruction in tumorsRemodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer.Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway.Angiogenic capacity of M1- and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9.Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors.MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer.Radiotherapy suppresses angiogenesis in mice through TGF-betaRI/ALK5-dependent inhibition of endothelial cell sproutingAntitumor activity of targeting SRC kinases in endothelial and myeloid cell compartments of the tumor microenvironmentPleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions.Resisting arrest: a switch from angiogenesis to vasculogenesis in recurrent malignant gliomasMatrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progressionTumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer.Effects of ionizing radiation on biological molecules--mechanisms of damage and emerging methods of detectionInfluence of bone marrow-derived hematopoietic cells on the tumor response to radiotherapy: experimental models and clinical perspectivesRole of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculatureTumor-fibroblast interactions stimulate tumor vascularization by enhancing cytokine-driven production of MMP9 by tumor cells.Endothelium originated from colorectal cancer stem cells constitute cancer blood vesselsInhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growthInhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment
P2860
Q24568374-8E964FA4-8FAB-494D-9CAD-84C45E054EB9Q24598701-F5A995D1-7926-4842-BD6A-5D778DED2603Q24606366-A4039F14-9228-4556-A488-FDA5B90E37FFQ24606406-2FE6C751-F139-4B63-A172-83504805CD3AQ26767150-5D47F8F6-CA76-4D91-BEAF-F22524FBEE25Q26823489-62D7AB17-A972-42C9-AE61-39FA6A494138Q26995733-94C8ED40-496F-4F8D-A553-A4F24052A49DQ26999217-E61977A9-99A6-434D-98F9-88AE98CC34C7Q27014189-E4D9725F-1675-4DED-85B6-8489FF02C6B3Q27022685-9079BEFF-4ED5-4D75-8A32-1A3959C92B5FQ27306938-D97C0646-163D-49A9-B1D8-82294EDAC94AQ27345020-0AFD9361-5F11-40CC-B6A1-66CA72E7F12CQ27853354-70A331D3-870F-4FD7-8747-AECA90F6971DQ28080006-69C8138C-86D8-4428-87FD-C63928A4D8CFQ28080262-C79B05EA-A1C3-4618-9847-A358543EAA1AQ28274091-47B68F78-80E7-403D-BD84-2CEAF68DC8CAQ28288148-01164920-F888-412E-8BCE-A96CCD144A28Q28559652-1E388825-12A3-40C6-BC65-29D52413C735Q28576485-7EA81501-9955-4EA3-A77D-26A891296EF5Q28749398-C4797648-330A-4E0C-B1C4-49AC0414560BQ29619858-A4BA89A0-07D6-4B8C-AF03-0A7610CF5752Q30408302-80D67DCB-4484-48E4-9DC8-61531188B5A8Q30476541-896F15CE-6AF9-44D6-93DC-1F5A87FF5F7CQ30490801-56097B0A-E6E4-4840-BB1A-4F61D3789595Q30559417-17596354-021F-4A3D-B391-9B6A18A482BCQ30930526-61DA5862-A04B-4D48-8649-70F7489C6BADQ33570512-7DFBB4A2-E9D2-4CCF-96F5-F5545FED8FCFQ33605773-D808B4BB-6A5F-4A2A-9AF7-B1316C8D3DDCQ33638344-0DC607B5-6865-4430-9953-D28EFFC32B0EQ33665623-76120F53-0AF5-43E0-A7C5-0BCE45C4EB61Q33685705-82EF431F-DC32-488C-9F8D-42EF7C5CFCEBQ33732496-4952B720-C0F2-49FA-B99A-6FEB6100D7C7Q33757096-CEA4322A-F3D9-4CFE-B3CD-355214056DFCQ33767975-628041B5-03B8-45FB-B364-B2368B7A963AQ33822929-2DBB10AC-81AE-45E8-843A-1A745C47CE65Q33824295-B8AA5FBE-E786-41B9-A0E8-31C2A467E166Q33829243-E7F89BE8-E72D-40B6-BCD5-6CF8DE1960F2Q33873312-3C69BF5F-F46C-40DF-A3BE-70A5A72A2ABAQ33915046-E912C329-F310-43CB-A2C6-6F268924BD01Q33929607-8DA8F5C6-9C36-45B5-992F-C30B36077335
P2860
Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Matrix metalloproteinase-9 is ...... w-derived myelomonocytic cells
@ast
Matrix metalloproteinase-9 is ...... w-derived myelomonocytic cells
@en
Matrix metalloproteinase-9 is ...... w-derived myelomonocytic cells
@nl
type
label
Matrix metalloproteinase-9 is ...... w-derived myelomonocytic cells
@ast
Matrix metalloproteinase-9 is ...... w-derived myelomonocytic cells
@en
Matrix metalloproteinase-9 is ...... w-derived myelomonocytic cells
@nl
prefLabel
Matrix metalloproteinase-9 is ...... w-derived myelomonocytic cells
@ast
Matrix metalloproteinase-9 is ...... w-derived myelomonocytic cells
@en
Matrix metalloproteinase-9 is ...... w-derived myelomonocytic cells
@nl
P2860
P1433
P1476
Matrix metalloproteinase-9 is ...... w-derived myelomonocytic cells
@en
P2093
J Martin Brown
P2860
P304
P356
10.1016/J.CCR.2007.11.032
P577
2008-03-01T00:00:00Z